Cargando…
Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment
A series of 30 non-covalent imidazo[1,2-a]quinoxaline-based inhibitors of epidermal growth factor receptor (EGFR) were designed and synthesized. EGFR inhibitory assessment (against wild type) data of compounds revealed 6b, 7h, 7j, 9a and 9c as potent EGFR(WT) inhibitors with IC(50) values of 211.22,...
Autores principales: | Kumar, Manvendra, Joshi, Gaurav, Arora, Sahil, Singh, Tashvinder, Biswas, Sajal, Sharma, Nisha, Bhat, Zahid Rafiq, Tikoo, Kulbhushan, Singh, Sandeep, Kumar, Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967119/ https://www.ncbi.nlm.nih.gov/pubmed/33803355 http://dx.doi.org/10.3390/molecules26051490 |
Ejemplares similares
-
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice
por: Bhat, Zahid Rafiq, et al.
Publicado: (2022) -
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation
por: Surapaneni, Sunil Kumar, et al.
Publicado: (2020) -
Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches
por: Goel, Kapil Kumar, et al.
Publicado: (2023) -
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats
por: Tikoo, Kulbhushan, et al.
Publicado: (2009) -
Imidazo[1,2-a]quinoxalines Derivatives Grafted with Amino Acids: Synthesis and Evaluation on A375 Melanoma Cells
por: Chouchou, Adrien, et al.
Publicado: (2018)